Blend Labs, Inc.
NYSE:BLNDSoftware - Application
-$0.03 today
- Market cap
- $218.02M
- Beta
- 1.09
- P/E (TTM)
- -71.2
- EPS (TTM)
- -$0.02
Volume 1.19M
Average 3.92M
BLND EBITDA Margin
EBITDA as a percentage of revenue.
Blend Labs, Inc.NYSE: BLND
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to -11.2%
EBITDA Margin was -11.2% in Q1 FY2026, up 11.5 pp from a year earlier. On a trailing-twelve-month basis it was 3.5%, up 19.7 pp year over year. Over 3 fiscal years it widened by 311.4 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 24.7% for the fiscal year ending Dec 2026, up from 2.4% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -11.2%-5.8 pp QoQ
- Last fiscal yearDec 2025
- 2.4%+22.0 pp YoY
- LTMMar 2026
- 3.5%+19.7 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +11.5 pp | +32.2 pp | +20.6 pp |
| 1 year | +22.0 pp | +22.4 pp | +0.4 pp |
| 3 years | +311.4 pp | +36.9 pp | -274.5 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 2.4%
- Year-over-year change
- +22.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.4% | +22.0pp |
| FY2024 | 2024-12-31 | -19.6% | +71.7pp |
| FY2023 | 2023-12-31 | -91.3% | +217.7pp |
| FY2022 | 2022-12-31 | -309.0% | -231.0pp |
| FY2021 | 2021-12-31 | -78.0% | — |
EBITDA Margin vs competitors
How BLND compares with its peers on the latest reported figures
- BLND's LTM Mar 2026 EBITDA Margin of 3.5% is the 7th highest of the 10 companies compared; the peer median is 9.4%.
- Its year-over-year change of +19.7 pp is the highest of 10, against a peer median of -1.1 pp.
- Over three fiscal years its change of +311.4 pp compares with a peer median of +7.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 28.6% | -32.7 pp | -20.4 pp | |
| LTM Mar 2026 | 25.7% | -1.1 pp | +14.1 pp | |
| LTM Mar 2026 | 11.6% | +2.0 pp | +43.1 pp | |
| LTM Mar 2026 | 10.1% | -1.1 pp | +4.1 pp | |
| LTM Mar 2026 | 9.4% | +8.2 pp | +7.4 pp | |
| LTM Mar 2026 | 9.3% | +3.4 pp | -8.4 pp | |
| LTM Mar 2026 | 3.5% | +19.7 pp | +311.4 pp | |
| LTM Mar 2026 | 2.2% | -2.8 pp | +25.7 pp | |
| LTM Mar 2026 | -1.0% | +10.1 pp | +34.8 pp | |
LAESSEALSQ Corp | FY2025 | -185.2% | -42.6 pp | -200.3 pp |
| Peer median (excluding BLND) | 9.4% | -1.1 pp | +7.4 pp | |
Competitors are the stored peer set for BLND. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 234.5M | 235.2M | 156.85M | 162.02M | 123.59M |
| Cost of Revenue | 118.51M | 145.55M | 75.71M | 71.48M | 32.42M |
| Gross Profit | 115.99M | 89.65M | 81.14M | 90.54M | 91.17M |
| Gross Margin | 49.5% | 38.1% | 51.7% | 55.9% | 73.8% |
| Research & Development | 92.22M | 138.09M | 81.59M | 46.09M | 32.84M |
| Selling, General & Admin | 212.88M | 224.37M | 130.82M | 86.61M | 79.19M |
| Operating Expenses | 313.23M | 835.83M | 237.36M | 140.16M | 112.03M |
| Depreciation & Amortization | 13.81M | 14.42M | 5.76M | 4.82M | 3.82M |
| EBITDA | (182.94M) | (726.85M) | (143.21M) | (31.74M) | 2.94M |
| EBITDA Margin | -78.0% | -309.0% | -91.3% | -19.6% | 2.4% |
| Operating Income | (197.24M) | (746.18M) | (156.22M) | (49.62M) | (20.86M) |
| Operating Margin | -84.1% | -317.3% | -99.6% | -30.6% | -16.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 11.28M | 24.79M | 30.81M | 6.75M | 0 |
| Other Income / Expenses | (10.79M) | (19.87M) | (23.56M) | 6.31M | 19.99M |
| Income Before Tax | (208.03M) | (766.05M) | (179.79M) | (43.31M) | (878K) |
| Pre-Tax Margin | -88.7% | -325.7% | -114.6% | -26.7% | -0.7% |
| Income Tax Expense | (38.89M) | (2.24M) | 94K | 109K | 249K |
| Net Income | (171.34M) | (768.61M) | (185.32M) | (49.6M) | (8.06M) |
| Net Margin | -73.1% | -326.8% | -118.2% | -30.6% | -6.5% |
| EPS (Basic) | (0.74) | (3.28) | (0.76) | (0.24) | (0.10) |
| EPS (Diluted) | (0.74) | (3.28) | (0.76) | (0.24) | (0.10) |
| Weighted Avg Shares | 230.32M | 234.16M | 245.21M | 253.92M | 258.95M |
| Weighted Avg Shares (Diluted) | 230.32M | 234.16M | 245.21M | 253.92M | 258.95M |
Blend Labs, Inc.
NYSE:BLND
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.